Complexa, Inc.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2008-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.complexarx.com
Clinical Trials
8
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
CXA-10 Study in Subjects With Pulmonary Arterial Hypertension
- First Posted Date
- 2019-08-12
- Last Posted Date
- 2020-08-26
- Lead Sponsor
- Complexa, Inc.
- Target Recruit Count
- 33
- Registration Number
- NCT04053543
- Locations
- 🇺🇸
University of Alabama, Birmingham, Alabama, United States
🇺🇸University of Arizona, Tucson, Arizona, United States
🇺🇸Anaheim Clinical Trials, LLC, Anaheim, California, United States
PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)
- First Posted Date
- 2018-02-28
- Last Posted Date
- 2020-08-10
- Lead Sponsor
- Complexa, Inc.
- Target Recruit Count
- 69
- Registration Number
- NCT03449524
- Locations
- 🇺🇸
University of Alabama, Birmingham, Alabama, United States
🇺🇸Arizona Pulmonary Specialists, Phoenix, Arizona, United States
🇺🇸University of Arizona, Tucson, Arizona, United States
FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)
- First Posted Date
- 2018-02-05
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Complexa, Inc.
- Target Recruit Count
- 33
- Registration Number
- NCT03422510
- Locations
- 🇺🇸
Alabama Neurology Consultants, Huntsville, Alabama, United States
🇺🇸Cedars Sinai Medical Center, Los Angeles, California, United States
🇺🇸Stanford University, Palo Alto, California, United States
A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males
- Conditions
- Acute Kidney Injury
- Interventions
- First Posted Date
- 2015-09-11
- Last Posted Date
- 2016-05-03
- Lead Sponsor
- Complexa, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT02547402
- Locations
- 🇺🇸
Jasper Clinical Research & Development, Inc., Kalamazoo, Michigan, United States
PK and PD of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male Subjects
- First Posted Date
- 2015-06-02
- Last Posted Date
- 2016-05-03
- Lead Sponsor
- Complexa, Inc.
- Target Recruit Count
- 43
- Registration Number
- NCT02460146
- Locations
- 🇺🇸
Jasper Clinical Research & Development, Inc., Kalamazoo, Michigan, United States
- Prev
- 1
- 2
- Next